Cardiac troponin elevation in patients with influenza virus infections

The association between acute infections and cardiac injury, including myocarditis and acute myocardial infarction, is now well established. We have performed a systematic literature review for analyzing the results of epidemiological studies that measured cardiac troponins (cTn) in patients with In...

Full description

Bibliographic Details
Main Authors: Giuseppe Lippi, Fabian Sanchis-Gomar
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Biomedical Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2319417020300883
_version_ 1811213058159149056
author Giuseppe Lippi
Fabian Sanchis-Gomar
author_facet Giuseppe Lippi
Fabian Sanchis-Gomar
author_sort Giuseppe Lippi
collection DOAJ
description The association between acute infections and cardiac injury, including myocarditis and acute myocardial infarction, is now well established. We have performed a systematic literature review for analyzing the results of epidemiological studies that measured cardiac troponins (cTn) in patients with Influenza virus infections. Overall, 14 articles were finally identified and analyzed. Taken together, the results of the scientific literature suggest that cTn elevation is a relatively rare phenomenon in patients with Influenza virus infection, with frequency generally comprised between 0 and 33%, more likely in elderly patients with significant comorbidities. In patients with modest cTn elevations, this phenomenon is apparently self-limited, transient and reversible, and especially involves patients with Influenza A (especially H1N1). In the minority of patients exhibiting an abrupt appearance of cardiovascular symptoms and concomitant elevation of cTn values, the relative increase of this biomarker reflects the presence of an underlying cardiac injury, that can be either myocarditis or an acute ischemic episode. Enhanced cTn values can also be more frequently observed in Influenza patients with complicated disease, in those developing acute respiratory distress syndrome and cardiac dysfunction, as well as in those at higher risk of death. cTn measurement shall be considered a valuable option in all patients developing acute cardiovascular symptoms during Influenza virus infections, as well as in those bearing cardiac or extra-cardiac comorbidities who bear a higher risk of complications.
first_indexed 2024-04-12T05:39:53Z
format Article
id doaj.art-724bf57c767b480db81b360b31577d51
institution Directory Open Access Journal
issn 2319-4170
language English
last_indexed 2024-04-12T05:39:53Z
publishDate 2021-04-01
publisher Elsevier
record_format Article
series Biomedical Journal
spelling doaj.art-724bf57c767b480db81b360b31577d512022-12-22T03:45:40ZengElsevierBiomedical Journal2319-41702021-04-01442183189Cardiac troponin elevation in patients with influenza virus infectionsGiuseppe Lippi0Fabian Sanchis-Gomar1Section of Clinical Biochemistry, University of Verona, Verona, ItalyDepartment of Physiology, Faculty of Medicine, University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain; Corresponding author. Department of Physiology, Faculty of Medicine, University of Valencia, Av. Blasco Ibañez, 15, 46010, Valencia, Spain.The association between acute infections and cardiac injury, including myocarditis and acute myocardial infarction, is now well established. We have performed a systematic literature review for analyzing the results of epidemiological studies that measured cardiac troponins (cTn) in patients with Influenza virus infections. Overall, 14 articles were finally identified and analyzed. Taken together, the results of the scientific literature suggest that cTn elevation is a relatively rare phenomenon in patients with Influenza virus infection, with frequency generally comprised between 0 and 33%, more likely in elderly patients with significant comorbidities. In patients with modest cTn elevations, this phenomenon is apparently self-limited, transient and reversible, and especially involves patients with Influenza A (especially H1N1). In the minority of patients exhibiting an abrupt appearance of cardiovascular symptoms and concomitant elevation of cTn values, the relative increase of this biomarker reflects the presence of an underlying cardiac injury, that can be either myocarditis or an acute ischemic episode. Enhanced cTn values can also be more frequently observed in Influenza patients with complicated disease, in those developing acute respiratory distress syndrome and cardiac dysfunction, as well as in those at higher risk of death. cTn measurement shall be considered a valuable option in all patients developing acute cardiovascular symptoms during Influenza virus infections, as well as in those bearing cardiac or extra-cardiac comorbidities who bear a higher risk of complications.http://www.sciencedirect.com/science/article/pii/S2319417020300883InfluenzaCardiac troponinMyocardial injuryCardiac injury
spellingShingle Giuseppe Lippi
Fabian Sanchis-Gomar
Cardiac troponin elevation in patients with influenza virus infections
Biomedical Journal
Influenza
Cardiac troponin
Myocardial injury
Cardiac injury
title Cardiac troponin elevation in patients with influenza virus infections
title_full Cardiac troponin elevation in patients with influenza virus infections
title_fullStr Cardiac troponin elevation in patients with influenza virus infections
title_full_unstemmed Cardiac troponin elevation in patients with influenza virus infections
title_short Cardiac troponin elevation in patients with influenza virus infections
title_sort cardiac troponin elevation in patients with influenza virus infections
topic Influenza
Cardiac troponin
Myocardial injury
Cardiac injury
url http://www.sciencedirect.com/science/article/pii/S2319417020300883
work_keys_str_mv AT giuseppelippi cardiactroponinelevationinpatientswithinfluenzavirusinfections
AT fabiansanchisgomar cardiactroponinelevationinpatientswithinfluenzavirusinfections